These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37816483)

  • 1. The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments.
    Van de Vyver T; Muntean C; Efimova I; Krysko DV; De Backer L; De Smedt SC; Raemdonck K
    J Control Release; 2023 Dec; 364():142-158. PubMed ID: 37816483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic Amphiphilic Drugs Boost the Lysosomal Escape of Small Nucleic Acid Therapeutics in a Nanocarrier-Dependent Manner.
    Van de Vyver T; Bogaert B; De Backer L; Joris F; Guagliardo R; Van Hoeck J; Merckx P; Van Calenbergh S; Ramishetti S; Peer D; Remaut K; De Smedt SC; Raemdonck K
    ACS Nano; 2020 Apr; 14(4):4774-4791. PubMed ID: 32250113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating β
    Merckx P; Conickx G; Blomme E; Maes T; Bracke KR; Brusselle G; De Smedt SC; Raemdonck K
    Eur J Pharm Biopharm; 2024 Apr; 197():114223. PubMed ID: 38367760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells.
    Joris F; De Backer L; Van de Vyver T; Bastiancich C; De Smedt SC; Raemdonck K
    J Control Release; 2018 Jan; 269():266-276. PubMed ID: 29146245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repositioning the antihistamine ebastine as an intracellular siRNA delivery enhancer.
    Muntean C; Blondeel E; Harinck L; Pednekar K; Prakash J; De Wever O; Chain JL; De Smedt SC; Remaut K; Raemdonck K
    Int J Pharm; 2023 Sep; 644():123348. PubMed ID: 37633539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visible light-switched cytosol release of siRNA by amphiphilic fullerene derivative to enhance RNAi efficacy in vitro and in vivo.
    Wang J; Xie L; Wang T; Wu F; Meng J; Liu J; Xu H
    Acta Biomater; 2017 Sep; 59():158-169. PubMed ID: 28511875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective Replacement of Cholesterol with Cationic Amphiphilic Drugs Enables the Design of Lipid Nanoparticles with Improved RNA Delivery.
    Bogaert B; Debisschop A; Ehouarne T; Van Eeckhoutte HP; De Volder J; Jacobs A; Pottie E; De Rycke R; Crabbé A; Mestdagh P; Lentacker I; Brusselle GG; Stove C; Verstraelen S; Maes T; Bracke KR; De Smedt SC; Raemdonck K
    Nano Lett; 2024 Mar; 24(10):2961-2971. PubMed ID: 38477058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs.
    Bogaert B; Sauvage F; Guagliardo R; Muntean C; Nguyen VP; Pottie E; Wels M; Minnaert AK; De Rycke R; Yang Q; Peer D; Sanders N; Remaut K; Paulus YM; Stove C; De Smedt SC; Raemdonck K
    J Control Release; 2022 Oct; 350():256-270. PubMed ID: 35963467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
    Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
    Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
    Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
    J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery.
    Hendershot J; Smith AE; Werfel TA
    J Vis Exp; 2019 May; (147):. PubMed ID: 31107463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing Angiogenesis Factors in Hypoxic Diabetic Wound Conditions by siRNA Delivery: Additive Effect of LbL-Gold Nanocarriers and Desloratadine-Induced Lysosomal Escape.
    Shaabani E; Sharifiaghdam M; Lammens J; De Keersmaecker H; Vervaet C; De Beer T; Motevaseli E; Ghahremani MH; Mansouri P; De Smedt S; Raemdonck K; Faridi-Majidi R; Braeckmans K; Fraire JC
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release.
    Gujrati M; Malamas A; Shin T; Jin E; Sun Y; Lu ZR
    Mol Pharm; 2014 Aug; 11(8):2734-44. PubMed ID: 25020033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging small molecule-induced endosomal escape of siRNA.
    Du Rietz H; Hedlund H; Wilhelmson S; Nordenfelt P; Wittrup A
    Nat Commun; 2020 Apr; 11(1):1809. PubMed ID: 32286269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of new pH-sensitive amphiphilic cationic lipids for siRNA delivery.
    Malamas AS; Gujrati M; Kummitha CM; Xu R; Lu ZR
    J Control Release; 2013 Nov; 171(3):296-307. PubMed ID: 23796431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform.
    Shi M; Zhang J; Huang Z; Chen Y; Pan S; Hu H; Qiao M; Chen D; Zhao X
    J Mater Chem B; 2020 Feb; 8(8):1616-1628. PubMed ID: 32010914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrostatic Attractive Self-Delivery of siRNA and Light-Induced Self-Escape for Synergistic Gene Therapy.
    Yang Y; Ning H; Xia T; Du J; Sun W; Fan J; Peng X
    Adv Mater; 2023 Jul; 35(30):e2301409. PubMed ID: 37084041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and perspective of inorganic nanoparticle-based siRNA delivery systems.
    Jiang Y; Huo S; Hardie J; Liang XJ; Rotello VM
    Expert Opin Drug Deliv; 2016; 13(4):547-59. PubMed ID: 26735861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
    Sato Y; Matsui H; Sato R; Harashima H
    J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.